XML 175 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 167.8 $ 112.2
Restricted cash 0.2 0.2
Accounts receivable, net 270.7 262.5
Inventories 222.5 205.8
Income tax receivable, net 4.6 8.6
Prepaid expenses and other current assets 20.4 31.5
Total current assets 686.2 620.8
Property, plant and equipment, net 542.3 510.2
Intangible assets, net 712.9 761.6
In-process research and development 29.0 50.0
Goodwill 266.6 259.7
Deferred tax assets, net 13.4 13.4
Other assets 76.9 13.7
Total assets 2,327.3 2,229.4
Current liabilities:    
Accounts payable 94.8 80.7
Accrued expenses 39.5 30.7
Accrued compensation 62.4 58.2
Debt, current portion 12.9 10.1
Contingent consideration, current portion 3.2 5.6
Other current liabilities 3.5 15.1
Total current liabilities 216.3 200.4
Contingent consideration, net of current portion 26.0 54.4
Debt, net of current portion 798.4 784.5
Deferred tax liability 63.9 67.5
Contract liabilities, net of current portion 85.6 62.5
Other liabilities 48.6 49.2
Total liabilities 1,238.8 1,218.5
Stockholders’ equity:    
Preferred stock, $0.001 par value; 15.0 shares authorized, 0 shares issued and outstanding at both December 31, 2019 and 2018 0.0 0.0
Common stock, $0.001 par value; 200.0 shares authorized, 52.9 shares issued and 51.7 shares outstanding at December 31, 2019; 52.4 shares issued and 51.2 shares outstanding at December 31, 2018 0.1 0.1
Treasury stock, at cost, 1.2 common shares at December 31, 2019 and 2018 (39.6) (39.6)
Additional paid-in capital 716.1 688.6
Accumulated other comprehensive loss, net (9.9) (5.5)
Retained earnings 421.8 367.3
Total stockholders’ equity 1,088.5 1,010.9
Total liabilities and stockholders’ equity $ 2,327.3 $ 2,229.4